What is the cash flow and balance sheet health after the quarter—specifically, free cash flow, debt levels, and capital‑expenditure plans? | BYND (Aug 06, 2025) | Candlesense
BYND

What is the cash flow and balance sheet health after the quarter—specifically, free cash flow, debt levels, and capital‑expenditure plans?

Based on the information you provided, the press release does not contain the specific financial details needed to answer the question.

The brief you supplied only tells us that Beyond Meat reported its Q2 2025 results, but it does not include:

Metric Information Provided
Free cash flow (the amount of cash generated after operating expenses and capital‑expenditures) Not disclosed in the excerpt
Debt levels (total debt, debt‑to‑equity, or any changes in borrowings) Not disclosed in the excerpt
Capital‑expenditure plans (planned investments in facilities, R&D, or other capital projects) Not disclosed in the excerpt

Because the release you quoted is a very high‑level announcement (a “globenewswire” headline and a brief note that the company “reported financial results”), it does not contain the detailed numbers or narrative that would normally appear in the full earnings release or the accompanying SEC filing (e.g., the Form 10‑Q). Those details would typically be found in:

  • The Management Discussion & Analysis (MD&A) section of the quarterly filing, where the company discusses free‑cash‑flow generation and any changes to its cash position.
  • The Consolidated Statements of Cash Flows and Balance Sheet sections, which would show the exact free cash‑flow figure, total debt (or lack thereof), cash on hand, and any debt maturities.
  • The Capital‑Expenditure (CapEx) outlook section of the earnings release or accompanying investor presentation, where the company outlines its planned spending for the remainder of the fiscal year.

What you can do to get the precise figures

  1. Locate the full press release – Usually the full press release on Beyond Meat’s investor‑relations website includes a summary table of key financial metrics (including free cash flow, cash balances, and debt).
  2. Review the Form 10‑Q for Q2 2025 – This SEC filing (available on SEC.gov or the company’s investor‑relations site) contains the audited cash‑flow statement and balance sheet, where you can read the exact free‑cash‑flow number and total debt.
  3. Check the accompanying earnings presentation – Companies often provide a “Capital‑Expenditure Guidance” slide that details planned CapEx for the upcoming quarters.

In short: The excerpt you provided does not contain the free‑cash‑flow, debt‑level, or capital‑expenditure information needed to answer the question. To obtain those details, you’ll need to review the full earnings release, the Form 10‑Q, or the accompanying investor presentation.

Other Questions About This News

How does the reported growth rate (or decline) in sales compare to previous quarters and to the broader plant‑based protein market? What are the margins (gross, operating, net) for Q2, and are there any notable cost‑structure changes impacting profitability? Are there any notable changes in geographic sales mix (e.g., North America vs. international markets) that could affect exposure to macro‑economic trends? What is the market's reaction so far (price movement, volume, options activity), and does it indicate any shift in sentiment or positioning? How does BYND's performance stack up against its main competitors (e.g., Impossible Foods, NestlĂ©, JBS Plant‑Based) in terms of volume, market share, and pricing power? Did the company address any regulatory or ESG developments that might influence its long‑term growth trajectory? What is the current inventory level versus demand, and are there any supply‑chain constraints that could affect future deliveries? Did Beyond Meat provide any guidance or outlook for Q3 2025 and FY 2025, and what assumptions underpin that guidance? Has there been any update on product launches, new partnerships, or expansion into new retail channels that could drive future demand? Did the press release mention any buy‑back programs, dividend plans, or other shareholder‑return initiatives? What were the key revenue and earnings metrics for Q2 2025, and how do they compare to analyst expectations?